- Do We Treat IgA Nephropathy and IgAVN Differently?
-
Dieter Haffner
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- Urine Microscopy as Predictor of Renal Replacement Therapy in Patients with Acute Kidney Injury
-
Mary ann Espina
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- IMAGINATION: A Global Phase 3 Trial of RO7434656, an Antisense Oligonucleotide Inhibitor of Complement Factor B, in IgA Nephropathy
-
Jonathan Barratt
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- Effect of intraoperative continuous renal replacement therapy on liver transplant recipient outcomes
-
Tai Yeon Koo
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- Use of Suboptimal Kidney Donors in Tx
-
Henry Pleass
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- A Case of Renal Injury Caused by Renal Artery Aneurysm in the Right Single Kidney: Improvement Following Embolization
-
Kiyoung Choi
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- Hematuria Resolution with the APRIL-Blocking Monoclonal Antibody, Sibeprenlimab, in Patients with IgA Nephropathy in a Phase 2 Randomized Controlled Trial
-
Muh Geot Wong
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- Fabry disease with genetic variants of unknown significance and concomitant immunoglobulin A nephropathy in a single center in China: case series and review
-
Huan Zhou
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- ABO Incompatible Kidney Transplantation in Asia Pacific
-
Yoshihiko Watarai
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- Risk factors of chronic kidney disease incidence as per data from the National Health Insurance Corporation in Korea : focus on patients with diabetes.
-
Ho Joon Ko
2024 ; 2024(1):
-
초록보기
PDF 원문보기